-
BARDA to Buy $2B in Covid-19 Vaccines, Therapies
The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines and treatments now in clinical trials.
-
FDA Halts Off-the-Shelf Engineered T-Cell Trial
A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple myeloma when a patient in the trial died.
-
Essay – Ten Years and Counting
If you dig deep into the Science & Enterprise archives, you’ll find this site began posting on 6 July 2010, exactly 10 years ago today.
-
Dual Antibodies in Trial to Prevent Covid-19 Infections
A cocktail of two synthetic antibodies will soon be tested in a clinical trial to prevent against Covid-19 infections, while also in a trial as a treatment for the disease.
-
Covid-19 Vaccines, Therapies – 6 July 2020
A continuing feature on Science & Enterprise is a weekly status report of vaccines and therapies for Covid-19 by the scientific illustration software company BioRender.
-
Infographic – Health Agencies Trusted for Covid-19 Info
As the U.S. enters its Independence Day in the midst of its worst-ever pandemic, a divided public most trusts its health agencies for information about the disease.
-
Mobile App Screens for Sleep Apnea
A medical software team designed a mobile app that records and analyzes a person’s sounds and sleep positions to detect signs of sleep apnea.
-
Biotech IDs Potent Covid-19 Antibodies
A company discovering therapeutic antibodies identified antibodies considered particularly effective in neutralizing SARS-CoV-2 viruses causing Covid-19 infections.
-
Polymer Boosts Insulin Speed, Stability
Researchers discovered a polymer compound added to insulin that in tests with pigs cuts insulin’s acting time in half and more than doubles its usable life.
-
Early Venture Investors Aim for Diverse Entrepreneurs
A new venture investment company is funding start-ups at their earliest stages, with a goal of increasing support for entrepreneurs from all backgrounds.